Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report
The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, w...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Teruyo Yamashita [verfasserIn] Jun Arata [verfasserIn] Shuko Kaito [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2023 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Journal of Plastic and Reconstructive Surgery ; 2(2023), 4, Seite 147-149 volume:2 ; year:2023 ; number:4 ; pages:147-149 |
|---|
| Links: |
|---|
| Katalog-ID: |
DOAJ099601400 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ099601400 | ||
| 003 | DE-627 | ||
| 005 | 20240414042905.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240414s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)DOAJ099601400 | ||
| 035 | |a (DE-599)DOAJ4164b770999b485c998c4bc6c1c20943 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RD1-811 | |
| 100 | 0 | |a Teruyo Yamashita |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events. | ||
| 650 | 4 | |a giant subcutaneous hematoma | |
| 650 | 4 | |a insulin injection | |
| 653 | 0 | |a Surgery | |
| 700 | 0 | |a Jun Arata |e verfasserin |4 aut | |
| 700 | 0 | |a Shuko Kaito |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal of Plastic and Reconstructive Surgery |g 2(2023), 4, Seite 147-149 |
| 773 | 1 | 8 | |g volume:2 |g year:2023 |g number:4 |g pages:147-149 |
| 856 | 4 | 0 | |u https://doaj.org/article/4164b770999b485c998c4bc6c1c20943 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.jstage.jst.go.jp/article/jprs/2/4/2_2022-0035/_pdf/-char/en |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2436-259X |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2023 |e 4 |h 147-149 | ||
| author_variant |
t y ty j a ja s k sk |
|---|---|
| matchkey_str |
teruyoyamashitajunaratashukokaito:2023----:insbuaeuhmtmascaewtsbuaeuislnnetoiaai |
| hierarchy_sort_str |
2023 |
| callnumber-subject-code |
RD |
| publishDate |
2023 |
| allfields |
(DE-627)DOAJ099601400 (DE-599)DOAJ4164b770999b485c998c4bc6c1c20943 DE-627 ger DE-627 rakwb eng RD1-811 Teruyo Yamashita verfasserin aut Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events. giant subcutaneous hematoma insulin injection Surgery Jun Arata verfasserin aut Shuko Kaito verfasserin aut In Journal of Plastic and Reconstructive Surgery 2(2023), 4, Seite 147-149 volume:2 year:2023 number:4 pages:147-149 https://doaj.org/article/4164b770999b485c998c4bc6c1c20943 kostenfrei https://www.jstage.jst.go.jp/article/jprs/2/4/2_2022-0035/_pdf/-char/en kostenfrei https://doaj.org/toc/2436-259X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2 2023 4 147-149 |
| spelling |
(DE-627)DOAJ099601400 (DE-599)DOAJ4164b770999b485c998c4bc6c1c20943 DE-627 ger DE-627 rakwb eng RD1-811 Teruyo Yamashita verfasserin aut Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events. giant subcutaneous hematoma insulin injection Surgery Jun Arata verfasserin aut Shuko Kaito verfasserin aut In Journal of Plastic and Reconstructive Surgery 2(2023), 4, Seite 147-149 volume:2 year:2023 number:4 pages:147-149 https://doaj.org/article/4164b770999b485c998c4bc6c1c20943 kostenfrei https://www.jstage.jst.go.jp/article/jprs/2/4/2_2022-0035/_pdf/-char/en kostenfrei https://doaj.org/toc/2436-259X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2 2023 4 147-149 |
| allfields_unstemmed |
(DE-627)DOAJ099601400 (DE-599)DOAJ4164b770999b485c998c4bc6c1c20943 DE-627 ger DE-627 rakwb eng RD1-811 Teruyo Yamashita verfasserin aut Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events. giant subcutaneous hematoma insulin injection Surgery Jun Arata verfasserin aut Shuko Kaito verfasserin aut In Journal of Plastic and Reconstructive Surgery 2(2023), 4, Seite 147-149 volume:2 year:2023 number:4 pages:147-149 https://doaj.org/article/4164b770999b485c998c4bc6c1c20943 kostenfrei https://www.jstage.jst.go.jp/article/jprs/2/4/2_2022-0035/_pdf/-char/en kostenfrei https://doaj.org/toc/2436-259X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2 2023 4 147-149 |
| allfieldsGer |
(DE-627)DOAJ099601400 (DE-599)DOAJ4164b770999b485c998c4bc6c1c20943 DE-627 ger DE-627 rakwb eng RD1-811 Teruyo Yamashita verfasserin aut Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events. giant subcutaneous hematoma insulin injection Surgery Jun Arata verfasserin aut Shuko Kaito verfasserin aut In Journal of Plastic and Reconstructive Surgery 2(2023), 4, Seite 147-149 volume:2 year:2023 number:4 pages:147-149 https://doaj.org/article/4164b770999b485c998c4bc6c1c20943 kostenfrei https://www.jstage.jst.go.jp/article/jprs/2/4/2_2022-0035/_pdf/-char/en kostenfrei https://doaj.org/toc/2436-259X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2 2023 4 147-149 |
| allfieldsSound |
(DE-627)DOAJ099601400 (DE-599)DOAJ4164b770999b485c998c4bc6c1c20943 DE-627 ger DE-627 rakwb eng RD1-811 Teruyo Yamashita verfasserin aut Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events. giant subcutaneous hematoma insulin injection Surgery Jun Arata verfasserin aut Shuko Kaito verfasserin aut In Journal of Plastic and Reconstructive Surgery 2(2023), 4, Seite 147-149 volume:2 year:2023 number:4 pages:147-149 https://doaj.org/article/4164b770999b485c998c4bc6c1c20943 kostenfrei https://www.jstage.jst.go.jp/article/jprs/2/4/2_2022-0035/_pdf/-char/en kostenfrei https://doaj.org/toc/2436-259X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2 2023 4 147-149 |
| language |
English |
| source |
In Journal of Plastic and Reconstructive Surgery 2(2023), 4, Seite 147-149 volume:2 year:2023 number:4 pages:147-149 |
| sourceStr |
In Journal of Plastic and Reconstructive Surgery 2(2023), 4, Seite 147-149 volume:2 year:2023 number:4 pages:147-149 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
giant subcutaneous hematoma insulin injection Surgery |
| isfreeaccess_bool |
true |
| container_title |
Journal of Plastic and Reconstructive Surgery |
| authorswithroles_txt_mv |
Teruyo Yamashita @@aut@@ Jun Arata @@aut@@ Shuko Kaito @@aut@@ |
| publishDateDaySort_date |
2023-01-01T00:00:00Z |
| id |
DOAJ099601400 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ099601400</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414042905.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240414s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ099601400</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ4164b770999b485c998c4bc6c1c20943</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD1-811</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Teruyo Yamashita</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">giant subcutaneous hematoma</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">insulin injection</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Surgery</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jun Arata</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shuko Kaito</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Plastic and Reconstructive Surgery</subfield><subfield code="g">2(2023), 4, Seite 147-149</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:147-149</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/4164b770999b485c998c4bc6c1c20943</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.jstage.jst.go.jp/article/jprs/2/4/2_2022-0035/_pdf/-char/en</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2436-259X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">2023</subfield><subfield code="e">4</subfield><subfield code="h">147-149</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
Teruyo Yamashita |
| spellingShingle |
Teruyo Yamashita misc RD1-811 misc giant subcutaneous hematoma misc insulin injection misc Surgery Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report |
| authorStr |
Teruyo Yamashita |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RD1-811 |
| illustrated |
Not Illustrated |
| topic_title |
RD1-811 Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report giant subcutaneous hematoma insulin injection |
| topic |
misc RD1-811 misc giant subcutaneous hematoma misc insulin injection misc Surgery |
| topic_unstemmed |
misc RD1-811 misc giant subcutaneous hematoma misc insulin injection misc Surgery |
| topic_browse |
misc RD1-811 misc giant subcutaneous hematoma misc insulin injection misc Surgery |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Journal of Plastic and Reconstructive Surgery |
| hierarchy_top_title |
Journal of Plastic and Reconstructive Surgery |
| isfreeaccess_txt |
true |
| title |
Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report |
| ctrlnum |
(DE-627)DOAJ099601400 (DE-599)DOAJ4164b770999b485c998c4bc6c1c20943 |
| title_full |
Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report |
| author_sort |
Teruyo Yamashita |
| journal |
Journal of Plastic and Reconstructive Surgery |
| journalStr |
Journal of Plastic and Reconstructive Surgery |
| callnumber-first-code |
R |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2023 |
| contenttype_str_mv |
txt |
| container_start_page |
147 |
| author_browse |
Teruyo Yamashita Jun Arata Shuko Kaito |
| container_volume |
2 |
| class |
RD1-811 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Teruyo Yamashita |
| author2-role |
verfasserin |
| title_sort |
giant subcutaneous hematoma associated with subcutaneous insulin injection in a patient with diabetes: a case report |
| callnumber |
RD1-811 |
| title_auth |
Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report |
| abstract |
The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events. |
| abstractGer |
The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events. |
| abstract_unstemmed |
The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
4 |
| title_short |
Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report |
| url |
https://doaj.org/article/4164b770999b485c998c4bc6c1c20943 https://www.jstage.jst.go.jp/article/jprs/2/4/2_2022-0035/_pdf/-char/en https://doaj.org/toc/2436-259X |
| remote_bool |
true |
| author2 |
Jun Arata Shuko Kaito |
| author2Str |
Jun Arata Shuko Kaito |
| callnumber-subject |
RD - Surgery |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| callnumber-a |
RD1-811 |
| up_date |
2024-07-03T23:32:35.303Z |
| _version_ |
1803602682509787136 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ099601400</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414042905.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240414s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ099601400</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ4164b770999b485c998c4bc6c1c20943</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD1-811</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Teruyo Yamashita</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Giant Subcutaneous Hematoma Associated with Subcutaneous Insulin Injection in a Patient with Diabetes: a Case Report</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The complications of insulin self-injection include subcutaneous bleeding, nerve damage, and subcutaneous induration due to repeated injection at the same site. However, considering the short length and thinness of the needle, it is unlikely that these complications will ever become serious. Here, we report a case of a 50-year-old man with abdominal giant hematoma due to insulin self-injection, which requires surgical treatment. The patient had obesity and took anticoagulants and steroids for 12 years. These drugs seemed to have affected the vessel wall and led to its compromise or destruction and subsequent hemorrhagic events.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">giant subcutaneous hematoma</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">insulin injection</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Surgery</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jun Arata</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shuko Kaito</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Plastic and Reconstructive Surgery</subfield><subfield code="g">2(2023), 4, Seite 147-149</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:147-149</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/4164b770999b485c998c4bc6c1c20943</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.jstage.jst.go.jp/article/jprs/2/4/2_2022-0035/_pdf/-char/en</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2436-259X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">2023</subfield><subfield code="e">4</subfield><subfield code="h">147-149</subfield></datafield></record></collection>
|
| score |
7.4032135 |